Related Experiment Video
Updated: Jun 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mitofusin-2 is a novel direct target of p53
Weilin Wang1, Xiaofei Cheng, Jianju Lu
1Key Lab of Combined Multi-organ Transplantation, Ministry of Public Health, Key Lab of Organ Transplantation, Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
Abstract:
The tumor suppressor p53 modulates transcription of a number of target genes involved in cell cycle arrest, apoptosis, DNA repair, and other important cellular responses. Mitofusin-2 (Mfn2) is a novel suppressor of cell proliferation that may also exert apoptotic effects via the mitochondrial apoptotic pathway. Through bioinformatics analysis, we identified a p53 binding site in the Mfn2 promoter. Consistent with this, we showed that the p53 protein binds the Mfn2 promoter directly both in vitro and in vivo. Additionally, we found that Mfn2 mRNA and protein levels are up-regulated in a p53-dependent manner. Furthermore, luciferase assays revealed that the activity of the wild-type Mfn2 promoter, but not a mutated version of the promoter, was up-regulated by p53. These results indicate that Mfn2 is a novel p53-inducible target gene, which provides insight into the regulation of Mfn2 and its associated activities in the inhibition of cell proliferation, promotion of apoptosis, and modulation of tumor suppression.
Insights
The tumor suppressor p53 directly binds the Mitofusin-2 (Mfn2) promoter, up-regulating its expression. This identifies Mfn2 as a novel p53-inducible gene involved in tumor suppression.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The tumor suppressor p53 is a key regulator of cellular responses, including cell cycle arrest, apoptosis, and DNA repair.
- Mitofusin-2 (Mfn2) is recognized for its role in suppressing cell proliferation and potentially inducing apoptosis through the mitochondrial pathway.
Purpose of the Study:
- To investigate the regulatory relationship between the tumor suppressor p53 and Mitofusin-2 (Mfn2).
- To determine if Mfn2 is a direct transcriptional target of p53.
Main Methods:
- Bioinformatics analysis to identify potential p53 binding sites in the Mfn2 promoter.
- In vitro and in vivo assays to confirm p53 binding to the Mfn2 promoter.
- Quantitative analysis of Mfn2 mRNA and protein levels.
- Luciferase reporter assays to assess promoter activity regulated by p53.
Main Results:
- A p53 binding site was identified in the Mfn2 promoter via bioinformatics analysis.
- Direct binding of p53 to the Mfn2 promoter was confirmed both in vitro and in vivo.
- Mfn2 mRNA and protein expression were found to be significantly up-regulated in a p53-dependent manner.
- Luciferase assays demonstrated that p53 enhances the activity of the wild-type Mfn2 promoter, but not a mutated version.
Conclusions:
- Mitofusin-2 (Mfn2) is identified as a novel p53-inducible target gene.
- These findings elucidate a new mechanism for Mfn2 regulation.
- This study provides insights into Mfn2's role in inhibiting cell proliferation, promoting apoptosis, and contributing to tumor suppression.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Master Transcription Regulators

